On Thursday, the Madras High Court ruled against Baba Ramdev led Patanjali Ayurved in connection for using the brand name 'Coronil' to market the product which claims to cure the COVID, infected patients. What Happened? Last month, Ardura Engineering Private Limited, a Chennai-based company, had filed the petition against Patanjali Ayurved...
Sun Pharmaceutical Industries, India's top pharmaceutical company, on Tuesday, launched Favipiravir under the brand name of ‘FluGuard’ in the market for treating mild to moderate coronavirus cases. ‘FluGuard’ will be available in the market from this week with a price of Rs. 35 per tablet. Sun Pharma with the help...
Jubilant Generics, a subsidiary of Jubilant Life Sciences, has launched remdesivir for injection called ‘JUBI-R’ in the Indian market. JUBI-R will come at a price of Rs. 4,700 per vial of 100 mg (lyophilized injection). Jubilant Generics with the help of its distribution network aims to provide the drug to...
An explanation has been requested by DCGI ( the Drugs Controller General of India) from Glenmark Pharmaceuticals scrutinizing it’s alleged “ false claims” on the implementation of the viral fabiflu ( favipiravir ) on COVID–19 patients with comorbidities( a denoting medical condition that co-occurs with another medical condition). After the...
Russian COVID Vaccination - Russia has come to be the first state to efficiently complete the human trials of the COVID vaccine. Russia's COVID vaccine has confirmed to be effective, as per the outcomes of the trials. The Chief Researcher Elena Smolyarchuk has been informed on 12th July 2020, that...
The medication will be accessible as a 200 mg tablet at a most extreme retail value (MRP) of Rs 3,500 for a portion of 34 tablets, Glenmark Pharmaceuticals said. The medication will be accessible as a remedy based drug for Rs 103/tablet, with suggested portion being 1,800 mg twice on...